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Background: Fetal cardiac intervention represents a potential advance in the treat-
ment of congenital cardiac lesions that increase in complexity during development.
Prenatal repair of a primary defect might prevent pathologic blood-flow patterns that
can result in hypoplasia of a cardiac chamber or great vessel. However, strategies to
optimize fetal myocardial protection have not been studied. A biventricular working
fetal heart preparation was used to evaluate the cardioprotective properties of
induced fibrillation and crystalloid cardioplegia.
Methods: Hearts from 16 fetal lambs at 115 to 125 days’ gestation were harvested
and perfused with Krebs-Henseleit solution. The descending aorta was ligated distal
to the ductal insertion and the branch pulmonary arteries were ligated to simulate the
parallel circulation of the fetus. Hearts were arrested with normothermic fibrillation
(n  8) or hypothermic crystalloid cardioplegia (n  8) before reperfusion with
Krebs-Henseleit solution. Baseline and postarrest myocardial function measure-
ments were obtained from analysis of pressure-dimension relationships.
Results: Fibrillatory and cardioplegic arrest were equally effective at preserving
postarrest systolic function (left ventricle, 70% 5% vs 68% 15%, P .52; right
ventricle, 68% 4.5% vs 65% 4.5%, P .26) and preventing increased diastolic
stiffness (left ventricle, 32%  5.3% vs 38%  11%, P  .24; right ventricle, 25%
 3.3% vs 27%  2.1%, P  .46). Myocardial water content was unchanged in
hearts arrested with fibrillation and cardioplegia (84%  1.5% vs 83.7%  0.9%,
P  .71).
Conclusions: Normothermic fibrillation and hypothermic crystalloid cardioplegia
provide equal protection of the fetal myocardium. In the setting of diminished fetal
myocardial reserve and because of the limited ability to manipulate the surrounding
temperature in the fetus, normothermic fibrillation may be preferable for in utero
repairs of selected congenital heart defects.
Fetal cardiac surgery offers the promise of in utero repair of complexcongenital defects that evolve during development. A primary lesion,such as valvular stenosis, might develop during primary morphogen-esis, altering blood flow. The resulting pathologic blood-flow patternin the developing heart induces hypoplasia of a heart chamber or greatvessel.1 It is this secondary lesion that causes hemodynamic instability
in the neonatal period.
Targeting the primary defect during the fetal period might restore normal
intracardiac flow patterns. Repair of the primary lesion should be relatively uncom-
plicated, allowing the fetal heart to rapidly recover and prepare for the transition to
From the Department of Cardiothoracic
Surgery, Stanford University School of
Medicine, Stanford, Calif.
Read at the Eighty-second Annual Meeting
of The American Association for Thoracic
Surgery, Washington, DC, May 5-8, 2002.
Dr Malhotra is a recipient of the National
Research Service Award (F32 HL 10339-
01) from the National Heart, Lung, and
Blood Institute of the National Institutes of
Health.
Received for publication May 29, 2002;
revisions requested July 8, 2002; revisions
received Oct 4, 2002; accepted for publica-
tion Oct 17, 2002.
Address for reprints: Sunil P. Malhotra,
MD, New York University School of Med-
icine, Department of Surgery, 530 First
Ave, NB-15N1, New York, NY 10016 (E-
mail: spmalhotra@yahoo.com).
J Thorac Cardiovasc Surg 2003;125:
1276-82
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/S0022-5223(02)73245-5
Surgery for Congenital Heart Disease Malhotra et al
1276 The Journal of Thoracic and Cardiovascular Surgery ● June 2003
CH
D
postnatal circulation. Fortunately, recent advances in car-
diovascular imaging have increased the likelihood of suc-
cessful fetal cardiac interventions. Currently, fetal echocar-
diography can be used to accurately diagnose certain
congenital heart defects as early as 10 to 12 weeks of
gestation.2
Numerous studies have demonstrated that fetal hemody-
namic stability after cardiac bypass is dependent on the
degree of stress to the fetoplacental unit.3,4 To that end,
limiting ischemic myocardial damage by optimizing myo-
cardial protection is essential to achieving a successful
outcome of fetal cardiac surgery. Appropriate cardioprotec-
tion strategies must reflect the unique aspects of fetal myo-
cardial physiology, including the impaired Frank-Starling
mechanism and diastolic compliance of the fetal myocardi-
um.5
Because prenatal repairs will, in certain circumstances,
require short periods of arrest, fibrillatory arrest should be a
safe approach for operations on the fetal heart. Studies in
fetal lambs found that regional myocardial blood flows were
preserved during cardiac bypass with normothermic fibril-
latory arrest.6,7 Jessen and colleagues8 found that fibrillation
caused a 15% increase in neonatal myocardial oxygen con-
sumption compared with 50% in studies on fibrillating adult
hearts. This observed difference may reflect the immaturity
of the myocardial contractile elements. Fetal myocardium
might exhibit further attenuation of increased myocardial
oxygen consumption after fibrillatory arrest because of its
inability to mobilize calcium stores. In this study the effi-
cacy of fibrillatory and cardioplegic arrest in the preserva-
tion of fetal myocardial function was examined by using an
isolated, biventricular, fetal working heart preparation that
closely simulates fetal cardiovascular physiology.
Methods
Experimental Preparation
Hearts from 16 fetal lambs (119  3.1 days’ gestation, 2.5  0.4
kg) were harvested and mounted on a controlled perfusion appa-
ratus (Figure 1). Pregnant ewes were sedated with intramuscular
ketamine (10 mg/kg). Ewes were then anesthetized with inhaled
isoflurane (2%), intubated, and mechanically ventilated. After ma-
ternal laparotomy and uterotomy, the fetal chest was exposed. A
midline sternotomy was performed, and the great vessels were
identified. A 1500-unit dose of heparin was administered to ac-
count for both the fetus and placenta. The descending aorta was
transected distal to the ductal insertion. The heart was removed
after transection of the inferior vena cava, the superior vena cava
(SVC), and the innominate artery. The heart was excised along
with a cuff of lung tissue to facilitate identification of the pulmo-
nary arteries and veins during mounting. The heart was placed in
Krebs-Henseleit bicarbonate buffer equilibrated with 95% CO2
and 5% O2 and transported to the water-jacketed perfusion appa-
ratus (Radnotti Glass Technology, Inc). The perfusate was main-
Figure 1. Isolated biventricular fetal heart preparation. Langendorff mode involves perfusion directly through the
aortic root. In the working heart mode perfusion is through the SVC cannula.
Malhotra et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 6 1277
CH
D
tained at a PO2 of 30 mm Hg by using blood gas measurements to
simulate the hypoxic conditions of the fetal heart.
During continuous aortic perfusion with Krebs-Henseleit at
37°C, the innominate artery was cannulated with a flexible plastic
cannula. A similar perfusion cannula was placed through the SVC
into the right atrium (RA). A pressure catheter was placed through
the transected descending aorta into the aortic root. The aorta was
then ligated distal to the ductus arteriosus. The branch pulmonary
arteries were ligated with metal clips to approximate the high fetal
pulmonary vascular resistance. A second pressure catheter was
secured in the RA through the inferior vena cava. Sonomicrometry
crystals (Sonometrics Corp) were fixed to the epicardium with
cyanoacrylic glue to measure changes in ventricular dimension.
Two crystals were placed at opposite ends of the short axis of the
left ventricle (LV), and an additional 2 crystals were similarly
placed on the short axis of the right ventricle (RV). High-fidelity
transducer-tipped catheters (Millar Instruments) were inserted into
both the LV and RV.
All animals received humane care in compliance with the
“Principles of Laboratory Animal Care” formulated by the Na-
tional Society of Medical Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources and published by the National In-
stitutes of Health. The protocol was approved by the Committee on
Animal Research at the University of California, San Francisco.
Data Acquisition
Pressure-dimension (PD) loops were generated by using the Sono-
view software package (Sonometrics Corp) from data acquired
from the crystals and the transducer-tipped catheters. Inflow oc-
clusion was used to generate descending PD loops. Heart rate,
aortic root pressure, and RA pressure were measured with Transpal
pressure transducers (Abbot Labs). Myocardial temperature was
measured with an electronic temperature probe (YSI).
Baseline Measurements
After 10 minutes of direct aortic perfusion (Langendorff mode),
perfusion through the SVC into the RA was initiated (working
heart mode). During the working heart mode, both ventricles eject
against a constant afterload created by 10 cm of 3⁄8-inch Tygon
polyvinyl tubing attached to the aortic outflow. Baseline hemody-
namic measurements were taken after 15 minutes in the working
heart mode.
Induction of Cardiac Arrest
Cardioplegic arrest (n  8) was induced and maintained for 30
minutes by means of a single infusion of Plegisol (Abbot Labs)
crystalloid cardioplegic solution at 6°C (20 mL/kg) into the aortic
root at a pressure of 20 mm Hg. Fibrillatory arrest (n  8) was
accomplished with a 1.5-V 60-cycle/s AC fibrillator (Department
of Bioengineering, University of California, San Francisco).
Hearts were continuously fibrillated for 30 minutes. A perfusion
pressure of 40 mm Hg was maintained through the aortic root
during the fibrillation period. At the end of the arrest period, the
fibrillation current was discontinued, and hearts were defibrillated
with 5 J to restore sinus rhythm.
Reperfusion
In the cardioplegia group aortic perfusion was restarted through
the aortic root after 30 minutes of cardiac arrest and was continued
for 10 minutes after mechanical activity returned. In the fibrillation
group the Langendorff mode was continued for 10 minutes once
sinus rhythm returned. In both groups the working mode was then
resumed, and postarrest measurements were taken after 15 min-
utes.
Calculations of Myocardial Function
Systolic, diastolic, and overall contractile function was calculated
from PD loops by using the Cardiosoft software package (Sono-
metrics Corp). End-systolic elastance (ESE) is an index of systolic
contractility calculated from the slope of the regression line that
fits the end-systolic points on the PD loops. Diastolic stiffness is
the end-diastolic PD relationship obtained from the exponential fit
of the end-diastolic PD points on the PD loop. Preload recruitable
stroke work (PRSW) is a preload-independent index of overall
myocardial function. PRSW represents the linear relationship be-
tween stroke work and end-diastolic volume.
Myocardial Water Determinations
On completion of the study, the left ventricular free wall was
excised and placed in a preweighed dish, and the wet weight was
obtained. The sample was heated at 80°C until the weight re-
mained constant to obtain the dry weight.
Statistical Analysis
All data are reported as means  SD. Analysis of statistical
significance was performed by the Student t test. All tests were
paired and 2-tailed. Significance was established at the 95% con-
fidence level. All values are expressed as mean  SD. Analyses
were performed with the Statview statistical package (SAS).
Results
Prearrest and postarrest hemodynamic data (heart rate, aor-
tic pressure, right atrial pressure, and cardiac output) are
presented in Table 1. These parameters are within the nor-
mal fetal physiologic range and are consistent between the
2 experimental groups.
There was no change in the prebypass and postbypass
X-axis intercept values (V0) for elastance (LV before by-
pass, 19.5  0.2; LV after bypass, 19.2  0.1; RV before
bypass, 18.6  0.2; RV after bypass, 18.8  0.1) or PRSW
(LV before bypass, 23.5 0.2; LV after bypass, 23.3 0.1;
RV before bypass, 22.2 0.2; RV after bypass, 22.4 0.1)
in the fibrillation or cardioplegia groups. Accordingly, ESE,
diastolic stiffness, and PRSW are represented by the change
of the slope after arrest or fibrillation.
Recovery of Systolic Function
Recovery of ESE is shown in Figure 2. Fibrillation and
cardioplegia provided equal protection of systolic function.
After cardiac arrest, the percentage recovery of left ventric-
ular ESE was 70%  5% in the fibrillation group and 68%
 15% with cardioplegic arrest (P  .52). Preservation of
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right ventricular systolic function was also statistically
equivalent with either technique, with a 68%  4.5% re-
covery of elastance in fibrillating hearts and 65%  4.5%
recovery of baseline ESE with cardioplegic arrest (P .26).
Protection From Diastolic Dysfunction
Cardioplegic and fibrillatory arrest equally preserved biven-
tricular diastolic compliance (Figure 3). Left ventricular
diastolic stiffness increased 32%  5.3% in the fibrillation
arrest group and 38%  11% in the cardioplegic arrest
cohort (P  .24). There was no statistically significant
difference in increased postarrest right ventricular diastolic
stiffness between the fibrillation and cardioplegia groups
(25%  3.3% vs 27%  2.1%, respectively; P  .46).
Preservation of Overall Myocardial Function
Figure 4 depicts the postarrest recovery of PRSW. Fibrilla-
tion and cardioplegia provided equal levels of protection of
overall left ventricular myocardial function, with 77% 
3.6% and 75%  13% recovery of PSRW, respectively (P
 .82). Recovery of right ventricular PRSW was 81% 
9.1% with fibrillatory arrest and 79%  4.5% with car-
dioplegic arrest (P  .69).
Myocardial Edema
There was no difference in postarrest myocardial edema
after either fibrillation or cardioplegia. Water content was
83.7%  0.9% and 84.0%  1.5% after fibrillatory and
cardioplegic arrest, respectively (P  .71, Figure 5). In
contrast, the baseline water content in age-matched control
fetal hearts was 77.8%  0.7%.
Discussion
Methods need to be developed to safely protect the fetal
myocardium during periods of cardiac intervention when
the heart is not beating. Myocardial protection is critical for
the fetus because of its limited cardiac reserve and increased
sensitivity to ischemic stress. Even neonatal myocardial
protection strategies may not be applicable to the develop-
ing heart because of the immaturity of the calcium regula-
tory apparatus in the fetal myocardium. The sarcoplasmic
reticulum (SR) differs significantly in morphology and
function in fetal myocytes. Myocardial SR content is mark-
edly reduced in the fetal myocardium.9 Furthermore, fetal
SR structure is immature because of decreased concentra-
tions of calcium ATPase and calsequestran.10 As a result,
regulation of myocardial calcium concentration is subopti-
mal in the fetus. These findings might explain the lack of
inotropic reserve of the fetal ventricle.11
This model is designed to mimic in vivo fetal cardiac
dynamics by including the ductus in the circuit and ligating
the branch pulmonary arteries so that both ventricles are
performing in parallel, as in fetal life. As with other isolated
heart preparations, this model does not account for the
effects of noncoronary collaterals or bronchial blood flow.
Nonetheless, use of an isolated preparation to study fetal
TABLE 1. Prearrest and postarrest hemodynamic data
Fibrillation Cardioplegia
Prearrest data
Heart rate 141 14.1 144.5 4.1
Mean aortic root pressure 30.4 5.5 32.8 3.2
Right atrial pressure 5.8 1.7 6.2 1.2
Cardiac output (mL/min) 94.6 12.6 95.5 7.6
Postarrest data
Heart rate 142.7 11.3 146.5 8.5
Mean aortic root pressure 32.9 3.4 33.5 6.4
Right atrial pressure 6.0 0.8 6.5 1.29
Cardiac output (mL/min) 88.7 13.0 90.3 18.4
Figure 2. Ventricular systolic function measured on the basis of ESE. Percentage recovery represents the ratio of
postarrest ESE to prearrest ESE. Fibrillation and cardioplegia provide equivalent protection of right and left
ventricular systolic function.
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cardiovascular physiology is advantageous because fetal
myocardial function can be assessed independent of placen-
tal dysfunction. Numerous studies have demonstrated the
adverse effects of fetal stress and, more specifically, fetal
cardiac bypass on the placental vascular resistance, resulting
in rapid cardiovascular decompensation.4,12
Interestingly, these studies revealed that normothermia
during induced fibrillation afforded fetal myocardial protec-
tion equal to that provided by hypothermic cardioplegia.
Hypothermia has been shown to decrease mitochondrial
calcium accumulation during periods of ischemia, thereby
limiting ischemia-related death.13 However, it is uncertain
whether the developing myocardium will benefit from this
advantage of hypothermia because of impaired myocardial
calcium uptake as a result of the immature sarcolemmal
structure of fetal myocytes.14 Furthermore, a cold-contrac-
ture phenomenon has been observed in the immature myo-
cardium, whereby a hypothermia-mediated inotropic effect
might exacerbate ischemic injury.15 Yet even if hypother-
mia were to be benign or even beneficial to the fetal myo-
cardium, it might be of limited practical use because fetal
surgery will likely occur with the fetus in the uterus, se-
verely compromising the ability to alter the temperature of
the surrounding tissues.
The cardioprotective qualities of fibrillation have been
extensively studied in mature myocardium. Early studies
by Hottentrot and associates16 demonstrated that fibril-
latory arrest caused subendocardial ischemia in adult
hearts after ventricular distention. Other authors have
found that fibrillation and hyperkalemic cardioplegic ar-
rest provide similar degrees of protection of the adult
myocardium.17,18 Studies in fetal lambs found that re-
Figure 3. Ventricular diastolic stiffness expressed as a percentage of postarrest stiffness compared with prearrest
values. Diastolic function of both ventricles is equally preserved after fibrillatory and cardioplegic arrest.
Figure 4. Recovery of myocardial contractility as measured on the basis of PRSW and expressed as a percentage
of baseline PSRW. Protection of biventricular contractile function was similar with normothermic fibrillation and
hypothermic cardioplegia.
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gional myocardial blood flows were maintained during
cardiac bypass with normothermic fibrillation and were
markedly increased after bypass.6 This phenomenon was
found to be perfusion dependent because the coronary
circulation was maximally dilated. Similar mechanisms
might account, in part, for the comparable levels of
myocardial protection afforded by fibrillation and cardio-
plegia in fetal hearts.
These studies examined the effects of ischemic or fibril-
latory arrest at 30 minutes. It is unclear whether similar
results would be obtained at longer arrest periods. Presum-
ably, prolonged duration of fibrillation would be less effec-
tive in protection of the fetal myocardium as a result of
increased myocardial oxygen consumption. Ideally, 30 min-
utes should be sufficient for the relatively uncomplicated
fetal interventions required to correct intracardiac flow dis-
turbances.
These results demonstrate that normothermic fibrillation
provides an equal degree of fetal myocardial protection as
hypothermic crystalloid cardioplegia. Fibrillation is more
practical than cardioplegia in the setting of fetal cardiac
surgery in that the difficulties of achieving effective hypo-
thermia during in utero interventions are avoided. More-
over, prolonged aortic crossclamping is not required, min-
imizing trauma to the fragile fetal vascular tissues.
Fibrillatory arrest may prove to be a valuable approach
during prenatal repairs.
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Discussion
Dr Davis C. Drinkwater (Nashville, Tenn). I very much en-
joyed the article. One point and question come to mind with this
potential technique. Myocardial distention on a ventricle might be
injurious, particularly in an immature heart under fibrillatory ar-
rest. Therefore, if you have a left-sided valve problem, presumably
you are going to try to open that valve. Are you concerned about
creating an insufficient valve under those conditions as opposed to
the crossclamp condition in terms of less precise pressure control
and causing left ventricular distention with possible poor myocar-
dial protection?
Dr Malhotra. You are always worried about distention when
using fibrillation, but if you can restore the patterns of blood flow,
you can avoid the potentially adverse effects of hypothermia. From
a practical standpoint, fibrillation is easier to accomplish in the
fetus than hypothermic cardioplegic arrest.
Dr John E. Mayer, Jr (Boston, Mass). I am sure this is not an
easy model to work with, and it has got to be a real challenge to
get these things to work. There are a few interesting questions that
sort of came up in my own mind, one of which is with the fetal PO2
values being quite a bit lower than they are in postnatal life, how
do you think that the effect of using a Langendorf preparation,
where you almost certainly have hyperoxic conditions, might yield
results that would be at variance with what you might see in a fetal
myocardium?
Dr Malhotra. That is excellent point. We actually did take that
into account, and we were very sensitive to the effects of hyper-
oxia. We did, at periodic intervals, perform blood gas analysis of
the perfusate and attempted to keep the PO2 between 30 and 40 mm
Hg.
Dr Mayer. Okay. And then the second issue, which is related:
have you considered using a blood prime or a blood perfusate in
your circuit rather than the crystalloid Langendorf type prepara-
tion?
Dr Malhotra. Actually, when we first thought about designing
the model, we wanted to use a blood prime, but, as you know, the
difficulty was in having enough fetal blood to use. Because of the
differences in fetal and adult hemoglobin, we did not want to use
pooled blood from adults.
Dr Frank W. Sellke (Boston, Mass). I agree, this is an out-
standing study; it is extremely novel and innovative. You only
gave one dose of cardioplegia crystalloid solution. Do you think
that provided optimal protection?
How could you modify the cardioplegic solution to take into
consideration the immature nature of the calcium-handling system
within the immature myocardium to provide optimal protection?
Dr Malhotra. Repeat your first question, please.
Dr Sellke. You gave one dose of the crystalloid cardioplegia.
Dr Malhotra. Right. That is one of the things we want to look
at in the future. Dosing of cardioplegia in neonates varies from
institution to institution, but from discussions with the perfusion-
ists and the staff at the University of California, we were comfort-
able with using one dose for a 30-minute arrest period. Of course,
in the future, we can look at multiple dosing. In terms of modifying
cardioplegia to account for the immaturity of fetal calcium regu-
lation, we presented our studies at the American Heart meeting this
past November, in which we altered the calcium concentration in
the cardioplegic solutions, and found that there is a profound
influence of calcium cardioplegic concentration.
Dr Erik A. Beyer (Cleveland, Ohio). I had a question about the
Langendorf model. You seem to suspend the heart from the aorta
and the pulmonary artery, is that correct?
Dr Malhotra. From the SVC and the aorta.
Dr Beyer. Does that have any effect on the hemodynamic
measurements that you have? Did you try to rest the heart from its
apex or posteriorly from the atrium to more simulate a more
normal situation?
Dr Malhotra. We went through a number of iterations with
this model, and initially we had started out with suspending or
having it rest on a platform, but we graduated to this and did not
find any difference in hemodynamic performance.
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